These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 10036894)

  • 21. A case of malignant syndrome associated with a parkinsonism patient.
    Sanga M; Nomura S
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Apr; 23(2):91-5. PubMed ID: 12762221
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Levodopa-induced dyskinesia and rotational behavior in hemiparkinsonian rats: independent features or components of the same phenomenon?
    Konitsiotis S; Tsironis C
    Behav Brain Res; 2006 Jun; 170(2):337-41. PubMed ID: 16621050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Perioperative management of Parkinson's disease].
    Shimohata T; Shimohata K; Nishizawa M
    Brain Nerve; 2015 Feb; 67(2):205-11. PubMed ID: 25681366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial.
    Shoulson I; Oakes D; Fahn S; Lang A; Langston JW; LeWitt P; Olanow CW; Penney JB; Tanner C; Kieburtz K; Rudolph A;
    Ann Neurol; 2002 May; 51(5):604-12. PubMed ID: 12112107
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A paradoxical acute effect of levodopa in de novo parkinsonian patients: worsening of some bradykinetic components.
    Pasetti C; Lualdi MM; Pinelli P
    Neurol Sci; 2003 Oct; 24(3):201-2. PubMed ID: 14598087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
    Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Postoperative respiratory failure in patients with cancer of esophagus and gastric cardia].
    Mao YS; Zhang DC; He J; Zhang RG; Cheng GY; Sun KL; Wang LJ; Yang L
    Zhonghua Zhong Liu Za Zhi; 2005 Dec; 27(12):753-6. PubMed ID: 16483491
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Time course of loss of clinical benefit following withdrawal of levodopa/carbidopa and bromocriptine in early Parkinson' s disease.
    Hauser RA; Koller WC; Hubble JP; Malapira T; Busenbark K; Olanow CW
    Mov Disord; 2000 May; 15(3):485-9. PubMed ID: 10830413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Embryonic mesencephalic grafts increase levodopa-induced forelimb hyperkinesia in parkinsonian rats.
    Steece-Collier K; Collier TJ; Danielson PD; Kurlan R; Yurek DM; Sladek JR
    Mov Disord; 2003 Dec; 18(12):1442-54. PubMed ID: 14673880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of levodopa on cognition of idiopathic Parkinson's disease].
    Alonso-Prieto E; Michel-Esteban E; Trujillo-Matienzo C; Palmero-Soler E
    Neurologia; 2004 Dec; 19(10):710-8. PubMed ID: 15568168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients].
    Hironishi M; Miwa H; Kondo T
    No To Shinkei; 2002 Feb; 54(2):127-32. PubMed ID: 11889758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selegiline: a second look. Six years later: too risky in Parkinson's disease.
    Prescrire Int; 2002 Aug; 11(60):108-11. PubMed ID: 12199263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of pramipexole on the onset of levodopa-related dyskinesias.
    Constantinescu R; Romer M; McDermott MP; Kamp C; Kieburtz K;
    Mov Disord; 2007 Jul; 22(9):1317-9. PubMed ID: 17534955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Motor complications of treatment with levodopa in Parkinson's disease].
    García-Escrig M; Bermejo-Pareja F
    Rev Neurol; 1999 Apr 16-30; 28(8):799-809. PubMed ID: 10363326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levodopa "drug holiday" with amantadine infusions as a treatment of complications in Parkinson's disease.
    Koziorowski D; Friedman A
    Mov Disord; 2007 May; 22(7):1033-6. PubMed ID: 17370308
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two cases of rapid onset Parkinson's syndrome following toxic ingestion of ethylene glycol and methanol.
    Reddy NJ; Lewis LD; Gardner TB; Osterling W; Eskey CJ; Nierenberg DW
    Clin Pharmacol Ther; 2007 Jan; 81(1):114-21. PubMed ID: 17186009
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Parkinson disease. Directed use of modern therapy].
    Möller JC; Wächter T; Oertel WH
    MMW Fortschr Med; 2001 May; 143 Suppl 2():45-50. PubMed ID: 11434257
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful perioperative management of patients with Parkinson's disease following gastrointestinal surgery: report of three cases.
    Fujii T; Nakabayashi T; Hashimoto S; Kuwano H
    Surg Today; 2009; 39(9):807-10. PubMed ID: 19779780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.